Incidence and Clinical Predictors of Deep Vein Thrombosis in Patients Hospitalized With Heart Failure in Japan

Ota, Satoshi; Yamada, Norikazu; Tsuji, Akiko; Ishikura, Ken; Nakamura, Mashio; M, Ito

doi:10.1253/circj.cj-08-0990

Cited by 26 publications

(25 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…5,6 Considering this, the first Japanese venous thromboembolism (VTE) treatment guidelines were published in 2004. 5 Acute PE often develops suddenly and has an associated mortality of 14% 7 in Japanese cases.…”

Section: Mdct Assessment Of Fondaparinux Therapy For Vtementioning

confidence: 99%

Multidetector-Row Computed Tomography-Based Clinical Assessment of Fondaparinux for Treatment of Acute Pulmonary Embolism and Acute Deep Vein Thrombosis in Japanese Patients

Nakamura

Okano²,

Minamiguchi

et al. 2011

Circ J

Self Cite

View full text Add to dashboard Cite

Section: Mdct Assessment Of Fondaparinux Therapy For Vtementioning

confidence: 99%

Multidetector-Row Computed Tomography-Based Clinical Assessment of Fondaparinux for Treatment of Acute Pulmonary Embolism and Acute Deep Vein Thrombosis in Japanese Patients

Nakamura

Okano²,

Minamiguchi

et al. 2011

Circ J

Self Cite

View full text Add to dashboard Cite

“…Poor contractibility with low cardiac output and aberrant flow through dilated cardiac chambers, blood stasis and endothelium dysfunctions all contribute to the thrombogenesis. Severe left ventricular dysfunction, NYHA class IV patients, poor inferior vena cava collapsibility, and no anticoagulant therapy are all associated with high risk for DVT [5]. HIV infection is a relevant risk factor in itself.…”

Section: Discussionmentioning

confidence: 99%

Left Hemibody Swelling in an HIV-Positive Patient with Congenital Heart Disease

Boattini

Almeida

Moura

et al. 2012

Case Reports in Vascular Medicine

View full text Add to dashboard Cite

We report the case of a 50-year-old HIV-positive woman with a congenital cyanotic heart disease who developed left axillary, subclavian, and brachiocephalic vein thrombosis and left lower aortopulmonary collateral arterial thrombosis, presenting as left hemibody swelling. We also briefly overview the literature regarding upper extremity deep vein thrombosis (UEDVT). Given the absence of other risk factors, it was our firm believe that our patient's UEDVT was due to a hypercoagulable state associated with congestive heart failure (CHF) and HIV infection.

show abstract

“…It is reported that the incidence of VTE in decompensated heart failure patients ranges from 4 to 26% in Western countries [12], the incidence of PE with congestive heart failure at autopsy ranges from 28 to 48% [13, 14]. A research in Japan reported that the incidence of DVT in heart failure patients was 11.2%, and the incidence is highest in patients classified as NYHA IV (NYHA II: 4.4%, NYHA III: 4.8%, NYHA IV: 25.5%, P < 0.01) [15]. One study in Thailand suggested that chronic pulmonary diseases and chronic heart failure were the two most common VTE risk factors in Caucasians, but this study revealed that the highest incidence of VTE was in rheumatologic diseases and the incidence of VTE in congestive heart failure was only 0.5% [16].…”

Section: Risk Factor and Incidencementioning

confidence: 99%

“…Additionally, VTE prophylaxis rates are high in Asian countries, such as Korea and Japan, but they are still low compared to the higher use of prophylaxis worldwide (50.2%) [56]. The rate in heart/respiratory failure prescribing VTE prophylaxis is estimated to be 46.9% in Korea [55] and 43.5% of heart failure patients received anticoagulant therapy according to a research in Japan [15]. The prophylaxis rates are extremely low in developing countries such as India, although the accurate prophylaxis rate has not been obtained in heart failure patients in this country.…”

Section: Preventionmentioning

confidence: 99%

Reduced cardiac function and risk of venous thromboembolism in Asian countries

Zhu

Tang

2017

Thrombosis J

View full text Add to dashboard Cite

Patients with reduced cardiac function are thought to have a higher risk of venous thromboembolism (VTE). Additionally, they are vulnerable to complications of pulmonary embolism (PE) as well as right heart failure (HF), which in return is supposed to increase the rate of mortality. Studies focusing on VTE in heart failure patients were rare in Asian countries before the 21st century. Nowadays, more and more data are becoming available in this field in Asia. It is already known that heart failure can increase the risk of VTE, but so far a consensus on this issue has not been reached for many years, not only in Asian countries but all over the world. This condition may be due to the detailed pathological advancement in Virchow’s triad and some other theories. In clinical practice, VTE, especially PE is difficult to diagnose in patients with heart failure because of overlapping symptoms (e.g. cough and chest pain) and the elevation of laboratory markers (e.g. probrain natriuretic peptide (NT-proBNP) and D-dimer in both heart failure and VTE patients). Management of VTE in heart failure patients is also controversial because heart failure patients always have complications, such as renal failure and hepatic failure, which increase the risk of bleeding. In this study, we analyzed data from China, Japan, Korea, Singapore and India mainly to get a better understanding of the research progress in VTE in patients with heart failure. The aim of this review is to discuss the risk, incidence, advancement of diagnosis, management and prevention of VTE in patients with heart failure in Asian countries.

show abstract

Incidence and Clinical Predictors of Deep Vein Thrombosis in Patients Hospitalized With Heart Failure in Japan

Cited by 26 publications

References 43 publications

Multidetector-Row Computed Tomography-Based Clinical Assessment of Fondaparinux for Treatment of Acute Pulmonary Embolism and Acute Deep Vein Thrombosis in Japanese Patients

Multidetector-Row Computed Tomography-Based Clinical Assessment of Fondaparinux for Treatment of Acute Pulmonary Embolism and Acute Deep Vein Thrombosis in Japanese Patients

Left Hemibody Swelling in an HIV-Positive Patient with Congenital Heart Disease

Reduced cardiac function and risk of venous thromboembolism in Asian countries

Contact Info

Product

Resources

About